It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
For instance, elevated CHAC1 mRNA levels are associated with increased recurrence risk in these cancers, underscoring its clinical relevance ( Pan-cancer analyses reveal that CHAC1 expression is highly variable, being upregulated in many cancers (e.g., breast, ovarian, lung, bladder carcinomas) and downregulated in others (e.g., certain head/neck, kidney, and brain cancers) (Zhang, T
If you want to open your own IV Therapy practice, check out and register for our free IV Nutrition masterclass.
Keeping food choices predictable can reduce overwhelm and help you stay nourished even when hunger feels different than usual
Diabetes Obes Metab (2016) 18(3):20316
The past two years have seen unprecedented momentum: GLP-1 therapies moved from niche to mainstream, supply issues arose then abated, and asset pipelines expanded beyond weight loss to whole-body medications